DG

Da-Wei Gong

RP Regeneron Pharmaceuticals: 2 patents #55 of 271Top 25%
UB University Of Maryland, Baltimore: 2 patents #5 of 126Top 4%
📍 Olney, MD: #5 of 28 inventorsTop 20%
🗺 Maryland: #417 of 3,746 inventorsTop 15%
Overall (2022): #167,390 of 548,613Top 35%
2
Patents 2022

Issued Patents 2022

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11504390 Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors Alan Shuldiner, Nehal Gosalia, Cristopher Van Hout, James Perry 2022-11-22
11331332 Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors James Perry, Alan Shuldiner, Nehal Gosalia, Cristopher Van Hout 2022-05-17